C.H. Robinson will acquire RXO for an implied $5.8 billion, or $30.25 per share, a 29% premium. RXO shares rose 21%; C.H. Robinson fell 8.1%. The deal is expected to close in H1 2027 with $300 million in annual cost synergies.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
